The 2023 American Association of Clinical Endocrinology (AACE) consensus statement on obesity pharmacotherapy notes: "GI-mediated adverse effects including dehydration sequelae may warrant dose reduction or extended titration intervals rather than discontinuation, particularly when anti-obesity medication efficacy has been established" 20
However, there is limited report about the effect of GLP-1 on dysfunction and autophagy of endothelial cells subjected to oxidative stress
The mechanism is deceptively simple
Medical professionals cannot diagnose or determine someones medication regimen purely based on visual appearance
These pathways help regulate appetite, fullness, insulin response, blood sugar control, and digestion
Endotoxin symptoms include fever, chills, myalgia, headache, nausea, vomiting, hypotension, shock, and death